Candel Therapeutics, Inc.

Needham, MA

UEI
MPKRJM6FJFL8
CAGE
47B55
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
117 Kendrick St #450, Needham, MA 02494, USA
Website
candeltx.com
Founded
1999
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Immuno-oncology for pancreatic cancer: a combination clinical trial with chemotherapy and radiation R44CA203336 National Cancer Institute (NIH) $3,521,301
Clinically suitable approach for gene-mediated therapy of cirrhosis. R43AA024000 National Institutes of Health $224,999
Improved system for producing adenoviral vectors R43CA132468 National Institutes of Health $213,871
Clinical and immunologic evaluation of prostatak for prostate cancer R44CA124032 National Institutes of Health $7,303,403
Clinical study of gmci in pancreatic cancer R43CA119847 National Institutes of Health $376,666

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Phusis Therapeutics, Inc. UEI JGZFBDAL61C4 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Phoenicia Biosciences, Inc. UEI NPAHDFK9M323 Weston, MA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Vireo Systems Inc. UEI Z6AJPJ82PFK3 Nashville, TN 325411 Medicinal and Botanical Manufacturing
Sequinbio LLC UEI SFB2M6GLFBJ3 Durham, NC 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Princeton UEI W8JELPX2UZB3 Princeton, NJ 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

SBA capabilities narrative

From the vendor's SBA profile

Clinical and preclinical research and development

Quick answers

Is Candel Therapeutics, Inc. registered in SAM.gov?

Yes. Candel Therapeutics, Inc.'s SAM.gov registration is active through July 27, 2027.

What is Candel Therapeutics, Inc.'s most recent federal award?

Candel Therapeutics, Inc.'s most recent federal grant award is Immuno-oncology for pancreatic cancer: a combination clinical trial with chemotherapy and radiation (R44CA203336), from National Cancer Institute (NIH), on December 23, 2015.

On GovTribe

See Candel Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login